SFM
RGNX icon

Sphera Funds Management’s Regenxbio RGNX Stock Holding History

Sphera Funds Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-95,564
Closed -$4.91M – 96
2019
Q2 		$4.91M Buy
+95,564
New +$4.77M 0.67% 42
2018
Q2 		– Sell
-100,000
Closed -$2.98M – 122
2018
Q1 		$2.98M Buy
100,000
+77,893
+352% +$2.27M 0.45% 62
2017
Q4 		$735K Buy
+22,107
New +$666K 0.09% 118

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sphera Funds Management's RGNX Position: Q3 2019 in Review

Sphera Funds Management sold out of Regenxbio (RGNX) in Q3 2019, closing a stake of 95,564 shares — an estimated $4.91M sold.

Sphera Funds Management first reported a position in RGNX in Q4 2017 and held it in 3 quarters. The position peaked at $4.91M in Q2 2019. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

  • Sphera Funds Management reported no remaining Regenxbio position as of Q3 2019 after selling out during the quarter.
  • Sphera Funds Management sold 95,564 Regenxbio shares in Q3 2019, an estimated $4.91M.
  • Sphera Funds Management first reported a position in Regenxbio in Q4 2017 and held it in 3 quarters.
  • Sphera Funds Management's Regenxbio position peaked at $4.91M in Q2 2019.
  • 168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Sphera Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.